Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Optogration	Freedom Photonics	Solfice	Additional Paid-in Capital	Additional Paid-in Capital Optogration	Additional Paid-in Capital Freedom Photonics	Additional Paid-in Capital Solfice	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Common Stock	Class A Common Stock Common Stock Optogration	Class A Common Stock Common Stock Freedom Photonics	Class A Common Stock Common Stock Solfice	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020													218,818,037					105,118,203
Beginning balance at Dec. 31, 2020	$ 148,741				$ 733,175				$ 34	$ 0	$ (584,501)		$ 22					$ 11
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of warrants (in shares)													15,574,037
Issuance of Class A common stock upon exercise of warrants	492,221				492,219								$ 2
Issuance of Class A common stock upon exercise of stock options (in shares)													4,011,750
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	4,753				4,753
Vendor payments under the stock-in-lieu of cash program (in shares)													291,940
Vendor payments under the stock-in-lieu of cash program	4,848				4,848
Acquisition (in shares)														370,034
Acquisitions		$ 6,527				$ 6,527
Issuance of earn-out shares (in shares)													10,242,703					6,970,467
Issuance of earn-out shares	(1)				(2)								$ 1
Conversion of Class B common stock into Class A common stock (in shares)													10,500,000					(10,500,000)
Conversion of Class B common stock into Class A common stock	0												$ 1					$ (1)
Share-based compensation	46,168				46,168
Payments of employee taxes related to stock-based awards /vested restricted stock units	(140)				(140)
Cash received from Gores on settlement of recapitalization of escrow	10				10
Other comprehensive income (loss)	66								66
Net loss	(164,093)										(164,093)
Ending balance (in shares) at Sep. 30, 2021													259,808,501					101,588,670
Ending balance at Sep. 30, 2021	539,100				1,287,558				100	0	(748,594)		$ 26					$ 10
Beginning balance (in shares) at Jun. 30, 2021													236,483,687					105,118,203
Beginning balance at Jun. 30, 2021	547,016				1,244,228				7	0	(697,254)		$ 24					$ 11
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)													1,920,137
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,547				1,547
Vendor payments under the stock-in-lieu of cash program (in shares)													291,940
Vendor payments under the stock-in-lieu of cash program	4,848				4,848
Acquisition (in shares)														370,034
Acquisitions		$ 6,527				$ 6,527
Issuance of earn-out shares (in shares)													10,242,703					6,970,467
Issuance of earn-out shares	(1)				(2)								$ 1
Conversion of Class B common stock into Class A common stock (in shares)													10,500,000					(10,500,000)
Conversion of Class B common stock into Class A common stock	0												$ 1					$ (1)
Share-based compensation	30,410				30,410
Other comprehensive income (loss)	93								93
Net loss	(51,340)										(51,340)
Ending balance (in shares) at Sep. 30, 2021													259,808,501					101,588,670
Ending balance at Sep. 30, 2021	539,100				1,287,558				100	0	(748,594)		$ 26					$ 10
Beginning balance (in shares) at Dec. 31, 2021													266,076,525					97,088,670
Beginning balance at Dec. 31, 2021	197,985				1,257,214				(908)	(235,871)	(822,487)		$ 27					$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)									(76,606)
Issuance of Class A common stock upon exercise of warrants (in shares)													405,752
Issuance of Class A common stock upon exercise of warrants	$ 19,003				19,003
Issuance of Class A common stock upon exercise of stock options (in shares)	1,713,280
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)													6,920,617
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	$ 2,846				2,845								$ 1
Retirement of unvested restricted common stock (in shares)													(48,204)
Vendor payments under the stock-in-lieu of cash program (in shares)													9,574,385
Vendor payments under the stock-in-lieu of cash program	60,678				60,677								$ 1
Optogration milestone awards (in shares)													1,632,056
Optogration milestone awards	11,751				11,751
Acquisition (in shares)															2,176,205	374,193
Acquisitions			$ 30,510	$ 3,361			$ 30,510	$ 3,361
Share-based compensation	102,408				102,408
Payments of employee taxes related to stock-based awards /vested restricted stock units	(2,773)				(2,773)
Other comprehensive income (loss)	(5,081)								(5,081)
Net loss	(301,122)										(301,122)
Ending balance (in shares) at Sep. 30, 2022												265,248,079	287,111,529				97,088,670	97,088,670
Ending balance at Sep. 30, 2022	42,960				1,484,996				(5,989)	(312,477)	(1,123,609)		$ 29					$ 10
Beginning balance (in shares) at Jun. 30, 2022													282,211,182					97,088,670
Beginning balance at Jun. 30, 2022	88,561				1,413,064				(6,005)	(312,477)	(1,006,059)		$ 28					$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)													2,735,219
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,102				1,101								$ 1
Retirement of unvested restricted common stock (in shares)													(4,648)
Vendor payments under the stock-in-lieu of cash program (in shares)													537,720
Vendor payments under the stock-in-lieu of cash program	16,920				16,920
Optogration milestone awards (in shares)													1,632,056
Optogration milestone awards	11,751				11,751
Share-based compensation	43,209				43,209
Payments of employee taxes related to stock-based awards /vested restricted stock units	(1,049)				(1,049)
Other comprehensive income (loss)	16								16
Net loss	(117,550)										(117,550)
Ending balance (in shares) at Sep. 30, 2022												265,248,079	287,111,529				97,088,670	97,088,670
Ending balance at Sep. 30, 2022	$ 42,960				$ 1,484,996				$ (5,989)	$ (312,477)	$ (1,123,609)		$ 29					$ 10